Scottish Scientist Receives $208K to Use Proteomics Tools in Colon Cancer Study | GenomeWeb
A University of Aberdeen researcher has received £105,000 [$208,000] to identify proteins for early-stage colon cancer diagnosis.
 
Pathology professor Graeme Murray will use the funding, from the Association for International Cancer Research, to detect and identify biomarkers for the cancer.
 
Murray said he expects to begin his work in early May, which will use mass spectrometry-based methods. The funding, spread over two years, will be used partly to hire a postdoc to help with the work.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.